MODERNA
(NASDAQ: MRNA)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

86.980

-1.390 (-1.57%)
Range - - -   (-%)
Open -
Previous Close 88.370
Bid Price 138.850
Bid Volume 8
Ask Price 139.500
Ask Volume 11
Volume 3,128,592
Value -
Remark
Delayed prices. Updated at 21 Feb 2024 04:59.
Data powered by

Upcoming Events

* Stock event date based on US timezone.

Earnings

Release Date 22 February 2024
View All Events


Loading Chart...

Please login to view stock data and analysis